CHARLES TOWN, W.Va., Sept. 12 ReBuilder MedicalTechnologies, Inc. today reported to its board of directors that it hasexpanded its international customer base to include England, Canada, NewZealand and Australia.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"These sales began to come in as a result of soldiers and relatives ofAmericans who experienced success using the ReBuilder System(R). Through wordof mouth and the targeted expansion of our international web outreach we sawan increase in sales from foreign countries." says Daena Carter, CFO forReBuilder Medical Technologies, Inc. "So a few months ago, we developed ourwebsite to accommodate these sales with its related shipping and tariffchallenges. Now we advertise in these countries and are receiving a steadyflow of customers. I expect that we will now increase sales in 2007 to over$4M. Next year should be even better as we identify additional distributors."
We have shipped to Australia, United Kingdom, Canada, New Zealand, andseveral other countries. "As a result of the increase in sales from foreigncountries we are actively seeking distributors and internationalrepresentation for our products" states Daena Carter. The InternationalDiabetes Federation estimates that more than 230 million people worldwide nowlive with diabetes. Neuropathy is known to affect more than 30% of alldiabetes sufferers. "As we recruit international partners in these and othercountries," says Daena Carter, "we ship to them in bulk and save on shippingcharges. In addition, overseas partners can translate the sales materialsinto their own language, and handle customer service without the translationissues. ReBuilder Medical Technologies, Inc. prides itself on excellentcustomer service and customers are always more comfortable taking to acustomer service representative in their own country, who speaks their owndialect, and understands their own customs and religious variations."
The ReBuilder System(R) is an electronic device that restores nervefunction, increases blood flow, cancels pain, and reduces numbness andtingling that sells for $399-$699 retail and is available via the Internet.
Twenty million, eight hundred thousand children and adults, or 7% of theU.S. population suffer from diabetes. Thirty percent of those diagnosed withdiabetes will eventually suffer from peripheral neuropathy, pain and numbnessin the feet and hands that can lead to complete loss of mobility, gangrene,and eventual amputations. $132 Billion per year is the current cost oftreating diabetes, or 1 of every 10 health care dollars spent. Neuropathysufferers constitute 33% of this market, or 43.56 billion dollars in potentialmarket. ReBuilder Medical Technologies, Inc. is a company in its infancy thathas targeted 1% of this market, or $43.5 million dollars in its next twomarket years, and is on course to meet this goal. Its only primarycompetition is from drug companies whose therapy has proven less successfuland prone to side-effects and addiction.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc is an emerging medical devicemanufacturer of innovative technologies founded by world renowned medicaldevice inventor David B. Phillips, Ph.D. ReBuilder Medical Technologies'sflagship product is its FDA registered ReBuilder System(R) for treatingperipheral neuropathy. Unlike current therapies for neuropathy (nervedisease) which focus on prescription drugs with powerful side effects, theReBuilder System(R) is a portable, battery powered medical product thatprovides a new non-surgical treatment which is non-invasive, has no sideeffects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum TreatmentSystem(TM) for treating the skin disease Molluscum Contagiosum which primar